Sweden-Based Mölnlycke Health Care Expands Brunswick, Maine, Operations
07/21/2025
The $135 million project will include space for new production lines and warehousing areas and a new converting line to assemble finished products.
“This expansion is a very big deal and the result of over a year’s hard work,” said Chris Biddle, general manager of US wound care manufacturing for Mölnlycke. “Besides creating new jobs, it will drive workforce development and bring technological advancements. It’s a win for Mölnlycke, for the local community and for patients. We’re excited about the positive impact it will have locally in Maine and across the broader US healthcare landscape.”
Mölnlycke Health Care is a medical device company focused on wound care and surgical solutions. The company is known for its wound care products featuring Safetac® technology, which is a soft silicone technology designed to minimize pain and tissue damage during dressing changes.
"This kind of investment reinforces the importance of the work MAME and our partners are doing to build strong pipelines of talent, modernize training programs and support the manufacturers who are powering Maine’s economy," noted John Lewis, executive director of the Manufacturers Association of Maine.
Project Announcements
Canadian-Based Romet Limited Plans Indianapolis, Indiana, Manufacturing Operations
07/21/2025
Catalent Expands Madison, Wisconsin, Production Operations
07/21/2025
Jabil Plans Rowan County, North Carolina, Manufacturing Operations
07/21/2025
Tate Ornamental Expands White House, Tennessee, Production Operations
07/18/2025
Lactalis USA Upgrades Walton-Buffalo, New York, Production Operations
07/18/2025
Brawo USA Forges Expands Laurens County, South Carolina, Operations
07/18/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
In Focus: AI Is Changing Incentives Math
Q2 2025
-
How to Choose the Right Site for Your Factory in 2025’s Volatile Landscape
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025
-
Manufacturing’s New Risk Game for Site Selection
Q2 2025